| Sr. No. | Name Of The Product | Indication |
| 1 | Azacitidine for Injection 100 mg | Refractory anemia |
| 2 | Bendamustine 100mg | |
| 3 | Bortezomib 3.5 & 2mg | |
| 4 | Bleomycin for Injection USP 15 Units & 30 Units | Testicular cancer and squamous cell cancer |
| 5 | Cabazitaxel injection 60 mg/1.5 ml along with Diluent for Cabazitaxel injection | Hormone refractory metastatic prostate cancer |
| 6 | Carboplatin injection BP 150 mg & 450 mg | Advanced ovarian cancer |
| 7 | Carmustine for Injection USP 100 mg along with Diluent for Carmustine for Injection | Brain Tumors |
| 8 | Cisplatin for injection USP 10 mg, 50 mg & 100 mg2 | Metastatic testicular tumors |
| 9 | Cladribine injection 100 mg | Hairy cell leukemia |
| 10 | Clofarbine | |
| 11 | Cyclophosphamide for Injection USP 200 mg, 500 mg & 1000 mg | Malignant Lymphomas |
| 12 | Cytarabine for Injection USP 100 mg, 500 mg, 1000 mg & 2000 mg | Non-lymphocytic leukemia |
| 13 | Daunorubicin for Injection USP 20 mg | Acute lymphocytic leukemia |
| 14 | Decitabine for Injection 50 mg | Myelodysplastic syndromes |
| 15 | Docetaxel Injection USP 20 mg, 80 mg &120 mg | Metastatic breast cancer |
| 16 | Doxorubicin hydrochloride for injection USP 10 mg & 50 mg | Acute lymphoblastic leukemia & acute myeloblastic leukemia |
| 17 | Epirubicin hydrochloride for injection 10 mg, 50 mg & 100 mg | Certain types of Breast cancer |
| 18 | Etoposide Injection USP 100 mg, 250 mg, 500 mg & 1000 mg | Lung cancer and testicular cancer |
| 19 | Fludarabine phosphate for injection USP 50 mg | B-cell chronic lymphocytic leukemia |
| 20 | Fluorouracil injection USP 250 mg & 500 mg | Colon cancer and Breast cancer |
| Oncology (Injection) |
|---|
| Sr. No. | Name Of The Product | Indication |
| 21 | Methotrexate injection USP 5 mg, 50 mg, 100 mg, 500 mg & 1000 mg | Breast cancer and Epidermoid cancer |
| 22 | Mitomycin for injection USP 2 mg, 5 mg, 20 mg & 40 mg | Adenocarcinoma of stomach or pancreas |
| 23 | Mitoxanthrone injection 20 mg, 25 mg & 30 mg | Secondary progressive multiple sclerosis & Acute non-lymphocytic leukemia |
| 24 | Oxaliplatin for injection USP 50 mg & 100 mg | Advanced colorectal cancer |
| 25 | Paclitaxel injection USP 30 mg, 100 mg, 150 mg, 250 mg, 260 mg & 300 mg | Breast/Lung/Pancreati c cancer |
| 26 | Pamidronate Disodium for injection USP 30 mg, 60 mg & 90 mg | Hypercalcemia associated with malignancy |
| 27 | Pemetrexed for Injection 100 mg & 500 mg | Metastatic nonsquamous non- small cell lung cancer |
| 28 | Temozolomide | |
| 29 | Thiotepa for injection USP 15 mg & 100 mg | Adenocarcinoma of Breast and Ovaries |
| 30 | Topotecan hydrochloride for injection 4 mg | Metastatic carcinoma of Ovaries |
| 31 | Vinblastine for injection 10 mg | Testicular cancer, Squamous cell carcinoma and lymphocytic leukemia |
| 32 | Vincristine sulfate injection USP 1mg | Acute leukemia |
| 33 | Vinorelbine injection USP 10 mg & 50 mg | Advanced (or) metastatic non-small lung cell cancer |
| 34 | Zoledronic Acid for injection 4 mg | Multiple myeloma & Bone metastases of solid tumors |
| 35 | Gemcitabine for injection USP 200 mg & 1000 mg | Metastatic non-small lung cancer |
| 36 | Idarubicin HCL Injection 5 mg & 20 mg | Acute myeloid leukemia |
| 37 | Ifosfamide injection USP 1000 mg & 3000 mg | Germ cell testicular cancer |
| 38 | Irinotecan hydrochloride injection USP 40 mg, 100 mg & 500 mg | Colorectal cancer |
